Frazier Healthcare Partners
VC
INVESTOR TYPE
Active
STATUS
32
PROFESSIONALS
354
INVESTMENTS
49
PORTFOLIO
157
EXITS
Description
Frazier Healthcare Partners is a private equity investment firm that is based in Seattle, Washington. The firm focuses on investing in companies operating in the pharmaceutical, healthcare services, medical products and biotechnology sectors.
Website
Formerly Known As
Frazier Healthcare
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1991
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
- Two Union Square, 601 Union Street
- Suite 3200
- Seattle, WA 98101
- United States
+1 (206) 000-0000
Frazier Healthcare Partners Investments (354)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| MedData | 31-Oct-2019 | Buyout/LBO | 00000 | Enterprise Systems (Healthcare) | Generating Revenue | 00000 00000 |
| 000 000000 000 000 | 31-Oct-2019 | 0000000000 | Clinics/Outpatient Services | Generating Revenue | 0000 00000000 | |
| 0000000 | 21-Oct-2019 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 3 | 0000000 00000 |
| 0000000 000 | 04-Sep-2019 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 0000000 00000 |
| 000000 00000000000 | 23-Aug-2019 | 00000 00000 | 0000 | Therapeutic Devices | Stealth | 0000 0000000 |
| 0000000 0000000000 | 15-May-2019 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 3 | 00000 00000 |
| 0000000 0000000000 | 15-May-2019 | 00000 000000 | Biotechnology | Clinical Trials - Phase 3 | 00000 00000 | |
| 0000000 | 23-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 3 | 0000000 00000 |
| ScoutBio | 29-Mar-2019 | Early Stage VC | 0000 | Biotechnology | Pre-Clinical Trials | 00000000 000000 00 |
| Imago BioSciences | 21-Mar-2019 | Later Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 2 | 0000000 00000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Frazier Healthcare Partners’s full profile, request a free trial.
Frazier Healthcare Partners Exits (155)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals | 25-Oct-2019 | IPO | 00000 | Completed |
|
| 00000 000000000000 | 18-Jul-2019 | 000 | 0000 | Completed |
|
| 0000000000 | 15-Jul-2019 | 000000000000000000 | Completed |
|
|
| 0000000000 0000000 | 01-May-2019 | 0000000000 | Completed |
|
|
| 000000 00000000000 | 22-Mar-2019 | 000000000000000000 | Completed |
|
|
| 00000000000 | 18-Mar-2019 | 000000000000000000 | 00000 | Completed |
|
| 0000000 | 15-Feb-2019 | 0000000000: 000000 | Completed |
|
|
| 0.0. 00000 0000 | 13-Feb-2019 | 0000000000 | Completed |
|
|
| Gritstone Oncology | 28-Sep-2018 | IPO | 00000 | Completed |
|
| Entasis Therapeutics | 26-Sep-2018 | IPO | 0000 | Completed |
|
Frazier Healthcare Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Frazier Healthcare Partners‘s full profile, request access.
Request full access to PitchBookFrazier Healthcare Partners Team (103)
39 Former Team Members
You’re viewing 5 of 103 team members. Get the full list »Frazier Healthcare Partners Co-Investors (141)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| HBM Healthcare Investments | 6 | 0 | 0 |
| Novo Holdings | 0 | 0 | 0 |
| Vivo Capital | 0 | 0 | 0 |
| HBM Partners | 0 | 0 | 0 |
| OrbiMed | 0 | 0 | 0 |